David Auerbach Email & Phone Number

Washington, DC, US

Cambridge, Cambridgeshire, GB

Strategy & Operations Leader: Lead delivery of business critical Oncology R&D (ORD) Chief Operating Officer (COO) programs and BAU business planning activities; provide strategic input for initiatives across COO functions.Global Head of PMO: Lead global team across US, UK, Spain and Canada of 40 FTEs and various contractors to drive non-drug.

Cambridge, Cambridgeshire, GB

• Lead critical cross-functional, transformational (non-drug) programs across global Oncology R&D with focus on driving increased efficiency and effectiveness through the Chief Operating Officer Program Management.
• Sponsor key initiatives as Oncology R&D representative on Gaithersburg (Maryland) Site Leadership Team, overseeing 5000+ local employees; drive strategic efforts related to long-term site vision and planning

Cambridge, Cambridgeshire, GB

• Led operational efficiency and effectiveness initiatives with demonstrated positive impact on Onc R&D organization - for example: developing our global long-term R&D office and lab site footprint strategy (through.
• Led Oncology R&D global business planning and operations network of 10+ functional areas, with focus on delivering key business process activities, connecting to key enabling functions (e.g., HR, Finance.
• Supported management of Onc R&D COO Non-Drug Project (NDP) portfolio; developed initial framework for COO PMO model and structure to further refine
• Sponsored key initiatives as Oncology R&D representative on Gaithersburg (Maryland) Site Leadership Team, overseeing 5000+ local employees
• Coached and mentored cross-functional Project Managers; people line manager of 4 Project Managers in 2020-2021 with strong focus on people development and growth opportunities

Cambridge, Cambridgeshire, GB

• Directly supported EVP ORD (Dr. Jose Baselga) as his Chief of Staff
• Delivered key strategic initiatives and efficiency NDP projects, ensuring collaboration across Oncology R&D functional teams from preclinical to phase 3 studies (Clinical, Translational, Discovery, Biometrics.
• Drove critical business and operational activities in close partnership with enabling functions (Finance, HR, Comms, Legal, Project/Portfolio Mgmt and others) and other enterprise business areas (Biopharm R&D, OBU.
• Managed team of 8 operational leaders and project managers to deliver 30+ operational / non-drug project initiatives, activities, events and projects
• Received strong Pulse survey scores that represent our operational management team is a great place to work (85% agree) and leadership communications is robust and transparent (90% agree)
• Managed 20-person ORD cross-functional senior leadership team (including driving agendas of key leadership meetings)

Cambridge, Cambridgeshire, GB

• Directly supported SVP, Head of Early Oncology R&D (Dr. Jean-Charles Soria) as Chief of Staff
• Led highly strategic initiatives and efforts across Early Oncology R&D leadership team and other senior leaders; owned business process deliverables and supported short, mid and long-term planning (MTP, LTP)
• Ensured strong collaboration and interaction among Early Oncology R&D leadership team functions including Clinical, Translational, Discovery, Strategy, External Alliances/Partnerships, Project Leadership and Business.
• Collaborated closely across all enabling functions (Finance, HR, Comms, etc) to deliver our scorecard and strategic goals, budget setting and tracking process, recruitment/HR activities, organizational design, internal.
• Managed 15-person Early Oncology R&D leadership team

Gaithersburg, Maryland, US

• Promoted from Senior Manager to Associate Director in 2018.
• Alliance Leadership: Managed cross-functional internal and external global teams consisting of R&D representatives from BD, Legal, IP, Contracts, Finance, PM, Research, Translational, Tox, CMC, Clinical Dev/Ops.
• Oncology External Development Leadership: Led and managed Oncology (focusing on phase 1 and 2 IO clinical programs) activities with key institutions, PIs and government agencies; managed strategic approach to.
• R&D Project Management: Managed projects across various TAs in varying stages of R&D (preclinical, IND submission, and clinical phase 1 and 2) via in-house development and external alliances; Focus on project.
• Founding Member of R&D Biologics Alliance Management leadership team; received first-ever Alliance Mgmt Excellence Award for MedImmune (from external global organization ASAP, 2018)

Paris, FR

• Optimizing existing molecules ideation workshop design / facilitation: prepared for, designed, and facilitated 4 workshops with 20+ global stakeholders across various functions (R&D, Manufacturing, Marketing.
• Co-development collaboration termination: led alliance and project management activities across 10+ workstreams including Clinical Science, Database Science, CMC, CTM, Safety/PV, Regulatory, Legal/Contracts.
• Product launch preparation for a new indication: supported project management coordination activities across Medical Affairs, Marketing, Market Access, PR/Communications and Sales teams
• Commercial organizational structure design optimization: clarified activities and RACIs across Market Access, Communications, Sales, Brand, Business Analytics, Emerging Products, Program Management, and.
• New product planning team design: developed and formalized future state recommendations through internal/external KOL interviews, case studies, and a current state analysis
• Internal HR recruitment strategy and toolkit development: co-led team that created candidate sourcing, screening, job requirement, key messaging, and internal/external communication guide deliverables

Tel-Aviv, IL

• Global Bioassays and Technology (GB&T)Promoted to Research Associate III (from Research Associate II) in February, 2012
• Researched, developed, qualified, validated, and ran samples in potency, pharmacokinetic (PK), and immunogenicity assays in non-clinical and human clinical studies involving biologics (innovative and.
• Lead analyst during non-clinical and clinical validation and sample analysis PK studies – managed secondary analyst(s)
• Laboratory Information Management System (LIMS) sample manager – received shipments, organized samples, and conducted data analysis
• Leveraged RHT Consulting experience to propose and develop a portfolio management plan at Teva Biopharmaceuticals USA; developed high-level NPV and IRR analysis of biologics portfolio

Leesburg, VA, US

• Developed 3-year strategic plan for local, clinical-stage pharmaceutical company focusing on novel treatments for infectious diseases
• Scheduled and conducted 20 interviews with company personnel and external subject matter experts to gain insight into core competency areas including disease, technical, and drug process timeline expertise
• Researched private/public industry, university, and government institutions for potential business development activities (licensing, M&A)
• Major contributor to market analysis of 50 disease areas by examining 40 dimensions including incidence rate, unmet need, geographical prevalence, development complexity, ability to execute, market size, scientific.
• Participated daily in virtual and in-person team meetings with over 20 verbal and written deliverables

Bethesda, MD, US

• First author on PNAS paper, June 2012 (Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor) - see link to paper below
• Conducted basic biomedical research involving HIV-1 related cytokines and cytokine receptors in the Laboratory of Immunoregulation in the National Institute of Allergy and Infectious Diseases under Dr. Paolo Lusso.
• Utilized nearly 20 immunological techniques to study HIV-1 related cytokines; summarized experiments and compiled reports weekly

Ms/Mba Dual Degree, Master Of Science In Biotechnology / Master Of Business Administration

Bs, Chemistry & Biology